Format

Send to

Choose Destination
See comment in PubMed Commons below
Rheum Dis Clin North Am. 2001 Feb;27(1):215-33, viii.

Emerging anabolic treatments for osteoporosis.

Author information

1
Maine Center for Osteoporosis Research and Education, St Joseph Hospital, Bangor, USA. rofe@aol.com

Abstract

Therapy for osteoporosis is principally centered on the use of agents that block bone resorption and supplementation with vitamin D and calcium. Although these drugs are effective in reducing the risk of subsequent fractures, and modestly increasing bone density, most patients being treated for osteoporosis still have low bone mass and a greater risk of fracture. Anabolic agents stimulate bone formation, strength, and mass. In addition, there is emerging evidence that anabolic agents can reduce subsequent fracture risk. The two most promising agents, parathyroid hormone (PTH) and GH/IGF-I, act to increase osteoblast mediated bone formation. A review of the potential usefulness of PTH and GH/IGF-I is presented.

PMID:
11285997
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center